What is CVE-2026-93936?

CVE-2026-93936 is a critical-severity vulnerability in Themerex Group Ipharm, classified under Deserialization of Untrusted Data. CVSS score: 9.8/10. Published 2026-10-10.

How severe is CVE-2026-93936?

Critical severity. CVSS v3 base score is 9.8 out of 10.

Deserialization in Themerex Group Ipharm

CVE-2026-93936

Deserialization of Untrusted Data vulnerability in ThemeREX Group IPharm ipharm allows Object Injection.This issue affects IPharm: from n/a through 1.2.4.

Vulnerability class: Insecure Deserialization

Published 2026-10-10.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

No EPSS score from FIRST.org yet. New CVEs usually get one within a few days; no score means no signal yet, not low risk. How EPSS works.

Affected products

Themerex Group Ipharm

Weakness classification (CWE)

CWE-502 — Deserialization of Untrusted Data

References

patchstack.com/database/wordpress/theme/ipharm/vulnerability/wordpress-ipharm-t… (vdb-entry)

Frequently asked questions

What is CVE-2026-93936?: CVE-2026-93936 is a critical-severity vulnerability in Themerex Group Ipharm, classified under Deserialization of Untrusted Data. CVSS score: 9.8/10. Published 2026-10-10.
How severe is CVE-2026-93936?: Critical severity. CVSS v3 base score is 9.8 out of 10.